A5087736234- Prostate Cancer Treatment and Research
- Bladder and Urothelial Cancer Treatments
- Adrenal Hormones and Disorders
- Urological Disorders and Treatments
- Epigenetics and DNA Methylation
- Patient Safety and Medication Errors
- Urologic and reproductive health conditions
- Cardiac Arrest and Resuscitation
- Adrenal and Paraganglionic Tumors
- Pituitary Gland Disorders and Treatments
- Prostate Cancer Diagnosis and Treatment
- Simulation-Based Education in Healthcare
- Urinary and Genital Oncology Studies
University of Washington
2024
Royal College of Surgeons in Ireland
2022
While the presence of adipose tissue and its involvement by prostatic cancer (extraprostatic extension) is well-recognized in prostate biopsies, transurethral resections (TURP) largely unexplored. Herein, 200 consecutive TURPs related specimens were reviewed, including a separate 3-year analysis containing cancer, with following data collected: fat, within quantity fat. For both fat specimen weight tumor volume recorded. Within specimens, was identified 20%; 55% had 2.5 mm tissue; number...
Despite the College of American Pathologists’ recommendation against diagnosing “fat invasion” in urinary bladder biopsies and transurethral resection tumor specimens (TURBT), some pathologists still consider this scenario as pathologic stage T3. However, a formal evaluation fat biopsies/TURBT has not been performed. Material obtained from TURBT is considered clinical staging (cT) that cystectomy true (pT). Herein, we analyze adipose tissue incidence/distribution, cancer involving fat,...
The 5th edition of WHO Classification Endocrine and Neuroendocrine Tumors (2022) introduced many significant changes relevant to endocrine daily practice. In this newsletter, we summarize the notable adrenal cortex based on classification [1].